Dieren, Netherlands

Bernardus Joseph Nitert

This inventor holds 1 USPTO granted patent. Top assignee: Theravance Biopharma R&d IP, LLC. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernardus Joseph Nitert. Retrieved from https://idiyas.com/inventor/bernardus-joseph-nitert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bernardus Joseph Nitert: Innovator in Pharmaceutical Compositions

Introduction

Bernardus Joseph Nitert is a notable inventor based in Dieden, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work is characterized by a focus on creating effective therapeutic solutions.

Latest Patents

Nitert holds a patent for the formulation of a pan-JAK inhibitor. The patent details pharmaceutical compositions comprising a specific compound, which is designed to provide therapeutic benefits. This formulation is aimed at addressing various medical conditions through its unique properties.

Career Highlights

Throughout his career, Nitert has been associated with Theravance Biopharma R&D IP, LLC. His role in this organization has allowed him to contribute to cutting-edge research and development in the pharmaceutical industry. His expertise in drug formulation has positioned him as a valuable asset in the field.

Collaborations

Nitert has worked alongside esteemed colleagues such as Yvonne Rosiaux and Marian E Van Der Veen. These collaborations have fostered a productive environment for innovation and have led to advancements in pharmaceutical research.

Conclusion

Bernardus Joseph Nitert's contributions to pharmaceutical compositions exemplify the impact of innovative thinking in medicine. His work continues to influence the development of effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…